Is Teva Pharmaceutical Industries Limited (TEVA) a Buy, Sell, or Hold?
NYSE : TEVA
Teva Pharmaceutical Industries Limited — Institutional Ownership
$30.81 USD
-$0.37 (-1.19%)
- Volume
- 2.74M
- Average Volume
- 6.31M
- Market Capitalization
- $35.88B
- P/E Ratio
- 22.76
- Dividend Yield
- 0.00%
- Price Target
- $41.00
- Year High
- $37.35
- Year Low
- $14.99
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.01
Institutional Ownership Summary
Institutional Ownership %
1.58%
Investors Holding
143
change: -546 | last: 689
Increased Positions
72
change: -257 | last: 329
Reduced Positions
27
change: -174 | last: 201
New Positions
23
change: -63 | last: 86
Sold Positions
537
change: 462 | last: 75
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -57.6829 | last: 0.5768
Total Invested
617.82M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-17 | Migdal Insurance & Financial Holdings Ltd | 61.69M | 5.37% |
| 2026-02-09 | Harel Insurance Investments & Financial Services Ltd | 72.33M | 6.30% |
| 2025-11-05 | FMR LLC | 24.64M | 2.10% |
| 2025-10-06 | Harel Insurance Investments & Financial Services Ltd | 58.12M | 5.10% |
| 2025-08-06 | FMR LLC | 58.14M | 5.10% |
| 2025-07-22 | Phoenix Financial Ltd. | 57.38M | 5.00% |
| 2025-07-17 | Menora Mivtachim Holdings Ltd | 57.4M | 5.00% |
| 2025-02-12 | FMR LLC | 81.98M | 7.20% |
| 2024-11-12 | Abigail P. Johnson | 62.74M | 5.54% |
| 2024-11-12 | FMR LLC | 62.74M | 5.54% |
| 2024-02-01 | The Phoenix Holdings Ltd. | 60.52M | 5.40% |
| 2022-02-11 | 95-1411037 | 13.0 | 12.00% |
| 2021-02-16 | 95-1411037 | 13.0 | 11.90% |
| 2021-02-03 | Wellington Group Holdings LLP | 310.79K | 0.03% |
| 2021-02-03 | Wellington Investment Advisors Holdings LLP | 310.79K | 0.03% |
| 2021-02-03 | Wellington Management Group LLP | 310.79K | 0.03% |
| 2020-02-14 | Capital Research Global Investors ** | 130.95M | 11.90% |
| 2020-01-28 | Wellington Management Group LLP | 81.12M | 7.43% |
| 2020-01-28 | Wellington Group Holdings LLP | 81.12M | 7.43% |
| 2020-01-28 | Wellington Investment Advisors Holdings LLP | 81.12M | 7.43% |
| 2020-01-28 | Wellington Management Company LLP | 77.22M | 7.07% |
| 2018-02-05 | Charles B. Johnson | 70.6M | 6.30% |
| 2017-10-31 | 10. | 55.79M | 14.70% |
| 2017-10-31 | 10. | 55.79M | 14.70% |
| 2017-10-31 | 10. | 23.4M | 5.00% |
| 2017-10-31 | 10. | 23.4M | 5.00% |
| 2016-03-30 | Teva Pharmaceutical Industries Limited | 1.11M | 7.70% |
| 2016-03-30 | Teva Canada Limited | 1.11M | 7.70% |
| 2016-03-28 | Teva Pharmaceutical Industries Limited | 2.17M | 9.99% |
| 2016-03-28 | Teva Pharmaceuticals USA, Inc. | 2.17M | 9.99% |
| 2015-12-10 | Teva Pharmaceuticals USA, Inc. (22-1734359) | 1.88M | 9.00% |
| 2015-12-10 | Teva Pharmaceutical Industries Limited (98-0478099) | 1.88M | 9.00% |
| 2011-01-28 | Teva Pharmaceutical Industries Limited | 5.44M | 6.30% |
| 2009-02-13 | Visium Asset Management, LP | 424.69K | 0.05% |
| 2009-02-13 | Jacob Gottlieb | 424.69K | 0.05% |
| 2008-04-03 | Teva Pharmaceutical Industries Limited | 4.46M | 13.80% |
| 2007-02-14 | FMR Corp. | 20.3M | 2.57% |
| 2007-02-14 | Edward C. Johnson 3d | 20.3M | 2.57% |
| 2006-02-14 | FMR Corp. | 34.24M | 5.36% |
| 2006-02-14 | Edward C. Johnson 3d | 34.24M | 5.36% |
| 2003-02-14 | EIN #75-3019302 | 10.01M | 3.90% |
| 2002-02-13 | EIN #84-0765359 | 8.76M | 6.80% |
| 2002-02-13 | Thomas H. Bailey | 8.76M | 6.80% |
| 2001-01-16 | Franklin Resources, Inc. | 3.29M | 2.60% |
| 2000-02-07 | Franklin Resources, Inc. | 4.92M | 7.90% |
| 1999-02-11 | Franklin Resources, Inc. | 4.51M | 7.20% |
TEVA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $31.21 | 1.15B | $35.86B | $3.56B | $17.38B | $49.69B |
| 2024-12-31 | $22.04 | 1.13B | $24.93B | $3.3B | $18.08B | $39.71B |
| 2023-12-31 | $10.44 | 1.12B | $11.68B | $3.23B | $20.15B | $28.61B |
| 2022-12-31 | $9.12 | 1.11B | $10.12B | $2.8B | $21.56B | $28.88B |
| 2021-12-31 | $8.01 | 1.1B | $8.83B | $2.16B | $23.46B | $30.12B |
| 2020-12-31 | $9.65 | 1.1B | $10.57B | $2.18B | $26.4B | $34.79B |
| 2019-12-31 | $9.80 | 1.09B | $10.69B | $1.98B | $27.34B | $36.06B |
| 2018-12-31 | $15.42 | 1.02B | $15.74B | $1.78B | $28.92B | $42.88B |
| 2017-12-31 | $18.95 | 1.02B | $19.25B | $963M | $32.48B | $50.77B |
| 2016-12-31 | $36.25 | 955M | $34.62B | $988M | $35.8B | $69.43B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30.12 | 1.16B | $34.82B | $3.74B | $16.91B | $47.98B |
| 2025-12-31 | $31.21 | 1.15B | $35.86B | $3.56B | $17.38B | $49.69B |
| 2025-09-30 | $20.20 | 1.15B | $23.17B | $2.2B | $17.09B | $38.06B |
| 2025-06-30 | $16.76 | 1.15B | $19.22B | $2.16B | $17.52B | $34.59B |
| 2025-03-31 | $15.37 | 1.14B | $17.49B | $1.7B | $16.94B | $32.73B |
| 2024-12-31 | $22.04 | 1.13B | $24.97B | $3.3B | $18.08B | $39.75B |
| 2024-09-30 | $18.02 | 1.13B | $20.42B | $3.32B | $19.28B | $36.37B |
| 2024-06-30 | $16.34 | 1.13B | $18.51B | $2.26B | $18.92B | $35.18B |
| 2024-03-31 | $13.91 | 1.12B | $15.62B | $2.99B | $19.94B | $32.57B |
| 2023-12-31 | $10.44 | 1.12B | $11.7B | $3.23B | $20.15B | $28.63B |
| 2023-09-30 | $10.20 | 1.12B | $11.43B | $2.25B | $20.3B | $29.48B |
| 2023-06-30 | $7.53 | 1.12B | $8.43B | $2.67B | $21.02B | $26.78B |